Avenio - About the company
Avenio is an unfunded company based in San Ramon (United States), founded in 2018. It operates as a Developer of an agentic AI platform for biopharma and CROs. Avenio has not raised any funding yet. The company has 844 active competitors, including 56 funded and 65 that have exited. Its top competitors include companies like Medidata, IQVIA and Verily.
Company Details
Developer of an agentic AI platform for biopharma and CROs. The platform supports clinical trial protocol development and execution. It streamlines literature reviews, data collection, and amendment processes. The platform also facilitates proactive adverse drug reaction monitoring.
Key Metrics
Founded Year
2018
Location
San Ramon, United States
Stage
Unfunded
Ranked
817th among 844 active competitors
Sign up to download Avenio's company profile
Avenio's funding and investors
Avenio has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Avenio's Competitors and alternates
Top competitors of Avenio include Medidata, IQVIA and Verily. Here is the list of Top 10 competitors of Avenio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Medidata 1999, New York City (United States), Acquired | AI-based clinical trial management software for researchers | $41.5M | 86/100 | |
2nd |  IQVIA 1982, Durham (United States), Public | Provider of clinical research and commercialization solutions for healthcare | $1.74M | 80/100 | |
3rd |  Verily 2015, Dallas (United States), Series D | Developer of precision health platforms and solutions using artificial intelligence | $2.8B | 78/100 | |
4th |  Tempus 2015, Chicago (United States), Public | Developer of genomic sequencing and artificial intelligence clinical diagnostic tools | $1.05B | 78/100 | |
5th |  Science 37 2014, Los Angeles (United States), Acquired | Provider of a suite solution for clinical trials for researchers | $106M | 73/100 | |
6th |  Signant Health 2000, Plymouth Meeting (United States), Acquired | Provider of a software solution for clinical trial management | $3.4M | 72/100 | |
7th | Viz.ai 2016, San Francisco (United States), Series D | Developer of an AI-powered platform for care coordination and disease detection | $252M | 69/100 | |
8th |  TriNetX 2013, Cambridge (United States), Acquired | Provider of clinical trial management software for researchers and professionals | $102M | 66/100 | |
9th | _1556172390155.png?devicePixelRatio=2&height=30&width=30){kind=logo} BrightInsight 2017, San Jose (United States), Series C | Provider of digital health solutions for clinical trials | $179M | 64/100 | |
10th | Wcg Clinical 2012, Princeton (United States), Acquired | CRO offering regulatory and ethical review services for clinical research | - | 64/100 | |
817th | Avenio 2018, San Ramon (United States), Unfunded | Developer of an agentic AI platform for biopharma and CROs | - | - | 16/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Avenio's competitors? Click here to see the top ones
Avenio's Investments and acquisitions
Avenio has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Avenio
Explore our recently published companies
- Sapphire - Lahore based, 1979 founded, Funding Raised company
- Datapile - Wilmington based, 2023 founded, Unfunded company
- Sarkari Rojgar - Mumbai based, 2026 founded, Unfunded company
- Excel Food - Guwahati based, 2008 founded, Unfunded company
- Sumcampus - Raipur based, 2017 founded, Deadpooled company
- Three Hyphens - Claymont based, 2020 founded, Unfunded company
